Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter Aeberhard is active.

Publication


Featured researches published by Peter Aeberhard.


Langenbeck's Archives of Surgery | 1981

[Parenteral antibiotic prophylaxis or oral antimicrobial bowel preparation for colorectal surgery (author's transl)].

Peter Aeberhard; M. Flückiger; J. Berger; A. Novak

SummaryA prospective randomized trial was designed to establish whether parenteral antibiotic prophylaxis was as effective as oral antimicrobial bowel preparation in preventing sepsis after colorectal surgery. Patients scheduled for elective resection of colorectal cancer received metronidazole and kanamycin either orally in the preoperative phase or parenterally as a short-term perioperative prophylaxis. The former regimen resulted in reduction of the microbial concentrations in the bowel contents in the absence of therapeutic serum concentrations at the time of operation, whereas the latter achieved therapeutic intraoperative serum levels without altering the colonic microflora. 72 patients were studied. There was no significant difference in the occurrence of postoperative sepsis between the two groups (a total of 72 patients). These results differ from those obtained at the Birmingham General Hospital using the same protocol, in which postoperative sepsis was significantly more common in the group of patients having oral bowel preparation. This difference was most probably due to an overgrowth of kanamycin-resistant coliforms during the period of oral antibiotic preparation. The presence of resistant organisms did not, however, result in failure of systemic prophylaxis. The authors conclude that short-term parenteral application is the safer method of antibiotic prophylaxis in colorectal surgery and is to be preferred to oral antimicrobial bowel preparation.ZusammenfassungIn einer prospektiven randomisierten Studie wurden zwei Methoden der Antibioticaprophylaxe in der colorectalen Chirurgie miteinander verglichen. 72 Patienten, bei denen eine elektive Operation wegen eines Colonoder Rectumcarcinoms durchgeführt wurde, erhielten Kanamycin and Metronidazol entweder oral, im Rahmen der präoperativen Darmvorbereitung, oder i. v., im Sinne einer kurzfristigen perioperativen Abschirmung. Bei der ersten Gruppe wurde eine Reduktion der aeroben und anaeroben Keimzahl im Darmlumen ohne therapeutische Serumkonzentrationen der verwendeten Medikamente erreicht, während bei der zweiten Gruppe wirksame interoperative Serumkonzentrationen ohne Veränderung der Keimzahlen im Darmlumen bestanden. Es ergab sich zwischen den beiden Gruppen keine signifikanten Unterschiede in der Häufigkeit der postoperativen Infekte. Diese Resultate stehen im Gegensatz zu denjenigen, die eine Arbeitsgruppe am Birmingham-General Hospital mit dem gleichen Studienprotokoll verzeichnete. In Birmingham waren postoperative Infektionen in der oral vorbereiteten Gruppe signifikant häufiger. Dieser Unterschied ist mit größter Wahrscheinlichkeit durch das Überwuchern Kanamycin-resistenter Bakterienstämme während der präoperativen oralen antibiotischen Vorbereitung bedingt. Das Vorhandensein resistenter Colistämme schien aber die Wirksamkeit der intravenösen Abschirmung nicht wesentlich zu beeinträchtigen. Die Autoren schließen daraus, daß die parenterale, kurzfristige Abschirmung der oralen Darmvorbereitung mit Antibiotica vorzuziehen ist.A prospective randomized trial was designed to establish whether parenteral antibiotic prophylaxis was as effective as oral antimicrobial bowel preparation in preventing sepsis after colorectal surgery. Patients scheduled for elective resection of colorectal cancer received metronidazole and kanamycin either orally in the preoperative phase or parenterally as a short-term perioperative prophylaxis. The former regimen resulted in reduction of the microbial concentrations in the bowel contents in the absence of therapeutic serum concentrations at the time of operation, whereas the latter achieved therapeutic intraoperative serum levels without altering the colonic microflora. 72 patients were studied. There was no significant difference in the occurrence of postoperative sepsis between the two groups (a total of 72 patients). These results differ from those obtained at the Birmingham General Hospital using the same protocol, in which postoperative sepsis was significantly more common in the group of patients having oral bowel preparation. This difference was most probably due to an overgrowth of kanamycin-resistant coliforms during the period of oral antibiotic preparation. The presence of resistant organisms did not, however, result in failure of systemic prophylaxis. The authors conclude that short-term parenteral application is the safer method of antibiotic prophylaxis in colorectal surgery and is to be preferred to oral antimicrobial bowel preparation.


Coloproctology | 1999

Präoperative Radiotherapie, totale mesorektale Exzision und postoperative Chemotherapie in der Behandlung der T3- und T4-Rektumkarzinome

Fabrizio Fasolini; Markus Notter; Martin Wernli; Bernhard Stamm; Peter Aeberhard; Rolf Schlumpf

ZusammenfassungMit einer exakt ausgeführten totalen mesorektalen Exzision (TME) können in der Behandlung des Rektumkarzinoms allein durch die chirurgische Technik sehr gute Resultate errecht werden, wie aus der neueren Literatur hervorgeht. Dennoch bleiben der alleinigen Chirurgie anatomische und tumorbiologische Grenzen gesetzt, welche der Einsatz adjuventer Maßnahmen rechtfertigen. In unseren Händen hath sich die präoperative hyperfraktionierte akzelerierte Radiotherapie mit 41,6 Gy, TME und postoperative Chemotherapie mit 5-FU als Therapieschema zur lokoregionären Beherrschung der Erkrankung bewährt, zumal in einer durchschnittlichen Nachbeobachtungszeit von zweieinhalb Jahren einzig bei einem von 50 Patienten ein Kokalrezidiv aufgetreten ist, was einer Lokalrezidivrate von 2% entspricht. Problematisch bleibt aber weiterhin die Fernmetastasierung, in unseren Fällen bei 12% der initial RO-resezierten Patienten und ausschließlich in Form von Lebermetastasen, welche Ziel weiterer Studien zur systemischen Behandlung des Leidens sein sollte.AbstractExactly accomplished total mesorectal excision (TME) for rectal cancer treatment has achieved very good results by surgery alone, as recently referred in the literature. However, there are anatomical and biological limits in only surgical treatment, advocating the usefulness of additional adjuvant procedures. In our experience, preoperative hyperfractionated accelerated radiotherapy with 41.6 Gy, TME and postoperative chemotherapy with 5-FU proved a success in locoregional control of the disease, leading to a local recurrence rate of 2% of 50 patients in a mean follow-up of 2.5 years after treatment. Despite of it, in our series distant metastases occurred only in the liver in 12% of patients resected for cure, and continues to be a problem which raises the need for other studies about systemical treatment of the disease.


Cancer Research | 1998

Prognostic Value of β1,6-Branched Oligosaccharides in Human Colorectal Carcinoma

Walter Seelentag; Wei-Ping Li; Shu-Fang Hsu Schmitz; Urs Metzger; Peter Aeberhard; Philipp U. Heitz; Jürgen Roth


European Journal of Surgery | 1997

Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer

Urban Laffer; Harder F; Peter Jäggi; Rudolf Maibach; Shu Fang Hsu Schmitz; Urs Metzger; M. Castiglione; Peter Aeberhard; Rudolf Egeli; Sergio Arma; Jean Pierre Barras; Veronique Dupont Lampert; Sebastiane Martinoli; Walter Müller; Rudolf Schröder; Rudolf Von Huben; Walter P. Weber; Aron Goldhirsch; Rudolph Maibach; Friedrich Gloor; Bernhard Stamm; Ursula Waltzer


Coloproctology | 1999

Preoperative radiotherapy, total mesorectal excision and postoperative chemotherapy for T3 and T4 rectal cancer

Fabrizio Fasolini; Markus Notter; Martin Wernli; Bernhard Stamm; Peter Aeberhard; Rolf Schlumpf


The Lancet | 1995

Adjuvant intraportal chemotherapy for colorectal cancer.

HughE. Mulcahy; M. J. G. Farthing; Aron Goldhirsch; UrbanTh Laffer; Urs Metzger; Peter Aeberhard; Ruedi Maibach; M. Castiglione


Langenbeck's Archives of Surgery | 1987

263. Adjuvante portale Chemotherapie bei colorectalen Carcinomen, eine multizenterstudie der schweizerischen arbeitsgemeinschaft für klinische krebsforschung (SAKK)

Urban Laffer; Urs Metzger; Peter Aeberhard; R. Egeli; S. Martinoli; W. Müller; F. Cavalli; M. Dürig; Harder F


Langenbeck's Archives of Surgery | 1987

Adjuvant portal liver infusion after curative resection of colorectal cancer. A randomized multicenter study of the swiss cooperative group on clinical cancer research

Urban Laffer; Urs Metzger; Peter Aeberhard; Rudolf Egeli; Sara Martinoli; Moonhor Ree; Franco Cavalli; M. D rig; Harder F


Archive | 1998

Prognostic Value of ß 1,6-BrancheclOligosaccharides in Human Colorectal Carcinoma1

Walter Seelentag; Wei-Ping Li; Shu-Fang Hsu Schmilz; Urs Metzger; Peter Aeberhard; Philipp U. Heitz


The Lancet | 1995

ADJUVANT INTRAPORTAL CHEMOTHERAPY FOR COLORECTAL CANCER. AUTHORS' REPLY

HughE. Mulcahy; M. J. G. Farthing; Aron Goldhirsch; U. T. Leaffer; Urs Metzger; Peter Aeberhard; R. Maibach; M. Castiglione

Collaboration


Dive into the Peter Aeberhard's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Harder F

University Hospital of Basel

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aron Goldhirsch

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

HughE. Mulcahy

St Bartholomew's Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge